Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Triple Negative Breast Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Recurrence 2 Unilateral Breast Neoplasms 1 Pain 1 Neoplasms 1 Lymphedema 1 Li-Fraumeni Syndrome 1 Inflammation 1 Hamartoma Syndrome, Multiple 1 Cystic Fibrosis 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Breast Cancer Invasive 1 Breast Cancer Female 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Exercise 5 Vitamin D 3 Resistance Training 3 Omeprazole 3 Etanercept 3 Dexmedetomidine 3 Ascorbic Acid 3 salicylsalicylic acid 2 palbociclib 2 epigallocatechin gallate 2 XENP 1595 2 Tea 2 Tablets 2 Surgical Procedures, Operative 2 Sufentanil 2 Spironolactone 2 Probiotics 2 Pioglitazone 2 Oxycodone 2 Nutrition Assessment 2 Morphine 2 Metformin 2 Ketorolac 2 Infliximab 2 Ibuprofen 2 Fish Oils 2 Endurance Training 2 Colchicine 2 Blood Specimen Collection 2 Aspirin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Mastectomy × Clear all

NCT06447532 2025-03-12

INFLAMMATE

Federal University of São Paulo

Enrolling by invitation

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡